Building on Early Successes of Immunomodulators in the Fight Against CancerDecision Resources
September 12, 2007
22 Pages - SKU: DECR1762153
More Oncology/Hematology reports by Decision Resources
TreatmentTrends®: Advanced/Metastatic Breast Cancer (US) 2012 by Decision Resources
This report series examines the current trends in the management of Advanced / Metastatic Breast Cancer from the perspective of medical oncologists. TreatmentTrends® are syndicated ...
Breast Cancer in Mexico by Decision Resources
Over the next decade, the diagnosed incidence of breast cancer (CaB) in Mexico will increase at almost three times the average annual growth ...
Oncology Patient Flow Model: Ovarian Cancer by Decision Resources
Query multiple epidemiological parameters over a 20 year forecast period in a data rich, graphical and interactive environment with Pharmacor Patient Flow Models.Please ...
Ovarian Cancer by Decision ResourcesSee all reports like this >>
Few novel therapies have entered the ovarian cancer (CaO) market in recent history, and oncologists are particularly keen to welcome new market entrants ...
We can help you find what you need. Call us or write us:
Need help in your search?
- Lymphoma Treatment Drugs Markets in China
- Metastatic Adenocarcinoma of The Pancreas – Pipeline Review, H1 2013
- Metastatic Hepatocellular Carcinoma (HCC) – Pipeline Review, H1 2013
- Metastatic Ovarian Cancer – Pipeline Review, H1 2013
- Recurrent Head And Neck Cancer Squamous Cell Carcinoma – Pipeline Review, H1 2013